Formulation customization: Applying Diffucaps Customized Release Technology to reduce dosing frequency and encourage patient adherence

|

article image
The pharmaceutical industry is driven to develop oral drug formulations that deliver significant patient benefits. Drug delivery technology can be leveraged to reduce dosing frequency, and therefore, help encourage patient adherence to prescribed therapeutic regimens. Benefits of successfully reducing dosing frequency Studies have shown a direct link between reduced dosing frequency and improved patient adherence.1 When patients are taking their medication more consistently, this can lead to a more successful course of treatment with positive outcomes. Several studies across various therapeutic categories have shown that once-daily (QD) dosing regimens can achieve equivalent efficacy, or even surpass the efficacy of their twice-daily (BID) or three-times-daily (TID) counterparts.

Spotlight

MedPharm Ltd

MedPharm is the leading specialist pharmaceutical development company, committed to the creation and development of topical and transdermal formulations for application to the skin, nail, mucous membranes, eye, nose and lung.

OTHER ARTICLES

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | April 11, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | April 11, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 11, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Spotlight

MedPharm Ltd

MedPharm is the leading specialist pharmaceutical development company, committed to the creation and development of topical and transdermal formulations for application to the skin, nail, mucous membranes, eye, nose and lung.

Events